Rezolute RZLT
NASDAQ RZLT
$4.58 +0.04 (+0.88%)
As of: Sep 4, 2026 · 3:59 PM EDT

Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023)

Rezolute (RZLT) posted Other Accumulated Expenses of $1.1 million for Q1 2023, up 4.67% sequentially from $1.1 million in Q4 2022, and up 46.73% YoY from $764000.0 in Q1 2022.

Analysis

Rezolute (RZLT) Other Accumulated Expenses (2014 - 2023) Analysis & Trends

Rezolute has reported Other Accumulated Expenses for 10 years, with the latest figure at $1.1 million in Q1 2023.

  • Quarterly Other Accumulated Expenses rose 46.73% year-over-year to $1.1 million in Q1 2023, while the trailing twelve-month figure through Mar 2023 was $1.1 million (up 46.73% YoY) and the FY2022 annual result came in at $243000.0, changed 0.41% from the prior year.
  • Other Accumulated Expenses rose to $1.1 million in Q1 2023 per RZLT's latest filing, from $1.1 million in the prior quarter.
  • Over five years, Other Accumulated Expenses peaked at $1.1 million in Q1 2023 and troughed at $122000.0 in Q3 2022.
  • A 5-year average of $486357.1 and a median of $388500.0 in 2020 frame the typical range for Other Accumulated Expenses.
  • The sharpest annual moves came in 2019 and 2022: Other Accumulated Expenses soared 361.4% in 2019, then sank 82.03% in 2022.
  • Over 5 years, Other Accumulated Expenses stood at $641000.0 in 2019, then plunged by 53.2% to $300000.0 in 2020, then surged by 59.0% to $477000.0 in 2021, then jumped by 124.53% to $1.1 million in 2022, then grew by 4.67% to $1.1 million in 2023.
  • According to Business Quant data, Other Accumulated Expenses over the past three periods registered $1.1 million, $1.1 million, and $122000.0 for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Rezolute 477.02 Mn 477.02 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 1.12 Mn
Dec 31, 2022 1.07 Mn
Sep 30, 2022 1.09 Mn
Jun 30, 2022 979,000.00
Mar 31, 2022 764,000.00
Dec 31, 2021 477,000.00
Sep 30, 2021 679,000.00
Jun 30, 2021 349,000.00
Mar 31, 2021 469,000.00
Dec 31, 2020 543,000.00
Sep 30, 2020 300,000.00
Jun 30, 2020 188,000.00
Mar 31, 2020 284,000.00
Dec 31, 2019 641,000.00
Sep 30, 2019 159,000.00
Jun 30, 2019 526,000.00
Sep 30, 2018 132,922.00
Jun 30, 2018 114,000.00
Mar 31, 2018 121,705.00
Dec 31, 2017 116,234.00